NCT07039747View on ClinicalTrials.gov

Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

treatment with DIELEN® Protect

treatment with DIELEN® Protect for 8 weeks at a dose of 5 grams, 3x a day

DRUG

treatment with placebo of DIELEN® Protect

treatment with placebo of DIELEN® Protect for 8 weeks at a dose of 5 grams, 3x a day

Trial Locations (1)

Unknown

RECRUITING

CHU de Rouen, Rouen

Sponsors

Collaborators (1)

Laboratoire Dielen
All Listed Sponsors
collaborator

Laboratoire Dielen

INDUSTRY

lead

University Hospital, Rouen

OTHER

NCT07039747 - Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter